Marketing
- NDA
- ANDA
- OTCs
- NDA/BLA Biologics & Biosimilars
FDA Expedited Pathways
- RMAT
- Orphan Drug
- Fast Track
- Breakthrough Therapy
- Priority Review
- Emergency Use Authorization
- Accelerated Approval Program
What phase of research do you need help with?
Select from USC, CHLA or LAC DHS
Select from a range of services
Marketing
FDA Expedited Pathways
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.